Conference · Pharmacovigilance
Pharmacovigilance Conference 2026
RWE Connect 2026 is the real-world evidence summit where pharmacovigilance takes center stage: signal detection, benefit-risk and the real-world data behind modern safety.
Two days in Boston with the safety, regulatory and RWE leaders protecting patients.
Free. Instant download. No obligation.
Why this one
Why the Safety Community Gathers Here
Modern pharmacovigilance runs on real-world data. This is where the safety field and the evidence field meet.
The agenda flow
Inside the Two Days
The program moves from the big picture to the practical, and from the signals to the decisions. Here is how it flows.
The agenda themes
What Is On the Agenda for Pharmacovigilance
The program is built around the questions that matter most to the safety community. See also the pharmacovigilance methods guide.
The speakers
Who Takes the Stage
The agenda draws speakers from across the pharmacovigilance and real-world evidence ecosystem.
Who is in the room
Who Attends RWE Connect 2026
A senior, focused audience, with safety and pharmacovigilance strongly represented.
Seniority is confirmed: 150+ attendees, around 60% at Director or VP level and above. The functional mix shown is indicative; confirmed registration splits are shared with sponsors from the live delegate list.
The experience
What to Expect
Two days built for learning, debate and the meetings that move work forward.
The sponsors
Sponsor and Exhibit
The exhibition and sponsorship program puts safety data and technology providers in front of the buyers. These are the main ways to take part.
Get involved
Ways to Take Part
Whether you want to learn, present or partner, there is a place for you at RWE Connect 2026.
More conferences
Explore RWE Connect
One summit, many communities. Explore the wider event and its themes.
Sponsor RWE Connect 2026
Reach the Pharmacovigilance and Safety Community
Sponsors reach the whole safety and evidence field in two focused days: 150+ attendees, around 60% at Director or VP level and above.
RWE Connect 2026
Get the Event Overview
See the full agenda themes and the safety trends shaping the field, then join the community in Boston.
- The full agenda and session tracks
- The kinds of speaker on stage
- How to attend, speak or sponsor
Free. Instant download. No obligation.
Pharmacovigilance Conference 2026: Common Questions
Is RWE Connect 2026 a pharmacovigilance conference?
RWE Connect 2026 is a real-world evidence summit where pharmacovigilance and real-world safety are core themes. The agenda covers signal detection, benefit-risk, regulatory compliance and AI in safety.
When and where is RWE Connect 2026?
14 to 15 October 2026 at the Hampton Inn by Hilton, Boston Seaport District, Boston, MA.
Who attends the pharmacovigilance conference?
Around 200 senior professionals across pharmacovigilance, safety, real-world evidence, epidemiology and regulatory science, about 60% at Director or VP level and above.
What pharmacovigilance topics are on the agenda?
Signal detection, real-world safety data, benefit-risk assessment, regulatory and compliance, AI in pharmacovigilance, and patient safety.
Is it relevant for drug safety and PV teams?
Yes. Real-world safety monitoring, signal detection and benefit-risk are among the core themes at RWE Connect 2026.
How do I attend RWE Connect 2026?
You can register to attend, apply to speak, or partner as a sponsor. Get in touch through the site to secure your place.
Can I speak at RWE Connect 2026?
Yes. Speaking opportunities are available for leaders with compelling pharmacovigilance and real-world safety work to share.
How can my organization sponsor RWE Connect 2026?
A range of sponsorship and exhibition packages is available. See the sponsorship page for options and to request the prospectus.
Is RWE Connect 2026 in person?
Yes. It is an in-person summit in Boston, built around face-to-face sessions, networking and pre-scheduled meetings.
What is the format of the conference?
Two days of keynotes, expert panels, practical workshops, a partnering lounge, networking and an exhibition.
How many people attend?
Around 200 senior attendees, with 40+ speakers and more than 200 pre-scheduled meetings facilitated.
How does real-world evidence relate to pharmacovigilance?
Real-world evidence underpins modern pharmacovigilance, powering signal detection and safety surveillance across large populations after a product is approved.
